Center for Scientific Review; Notice of Closed Meeting, 48898 [2023-15992]

Download as PDF 48898 Federal Register / Vol. 88, No. 144 / Friday, July 28, 2023 / Notices Estimated number of respondents Data collection instrument(s) Responses per respondent Average burden hour per response * Credentialing by Proxy Intake Form ............................................................. Affiliation Verification ..................................................................................... Education Verification ................................................................................... Malpractice Verification ................................................................................. Peer Reference Verification .......................................................................... 250 4,225 3,289 2,535 6,180 1 1 1 1 1 Total ....................................................................................................... 20,069 ........................ .25 .25 .25 .25 .25 (15 (15 (15 (15 (15 min) min) min) min) min) Total annual burden (current) ** ...... ...... ...... ...... ...... 63 1,056 822 634 1,545 ........................... 6,354 For ease of understanding: * Average Burden Hour per Response are provided in actual minutes. ** Total Annual Burden (Current) are provided in hours. Annual number of respondents and average burden hour were factored based on total IHS providers credentialed and privileged Calendar Year 2022, accreditation requirements with estimates of verification per applicant, and respondent estimate time of completion in the paragraphs above. There are no capital costs, operating costs, and/or maintenance costs to respondents. Requests for Comments: Your written comments and/or suggestions are invited on one or more of the following points: (a) Whether the information collection activity is necessary to carry out an agency function; (b) Whether the agency processes the information collected in a useful and timely fashion; (c) The accuracy of the public burden estimate (the estimated amount of time needed for individual respondents to provide the requested information); (d) Whether the methodology and assumptions used to determine the estimates are logical; (e) Ways to enhance the quality, utility, and clarity of the information being collected; and (f) Ways to minimize the public burden through the use of automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. P. Benjamin Smith, Deputy Director, Indian Health Service. [FR Doc. 2023–16011 Filed 7–27–23; 8:45 am] BILLING CODE 4165–16–P Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 23–005: NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01) 2. Date: August 8, 2023. Time: 9:00 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Megan L. Goodall, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–8334 megan.goodall@ nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 24, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health lotter on DSK11XQN23PROD with NOTICES1 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Center for Scientific Review; Notice of Closed Meeting [FR Doc. 2023–15992 Filed 7–27–23; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. VerDate Sep<11>2014 17:16 Jul 27, 2023 Jkt 259001 PO 00000 Frm 00113 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Review of Applications to Research Projects in Physical Sciences Oncology. Date: September 29, 2023. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W640, Rockville, Maryland 20850 (Virtual Meeting). Contact Person: Saejeong J. Kim, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Rockville, Maryland 20850, 240–276–7684, saejeong.kim@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–3: NCI Clinical and Translational Cancer Research. Date: October 12, 2023. Time: 9:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850 (Virtual Meeting). Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer, Special Review E:\FR\FM\28JYN1.SGM 28JYN1

Agencies

[Federal Register Volume 88, Number 144 (Friday, July 28, 2023)]
[Notices]
[Page 48898]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15992]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA-OD-23-005: NIH Research Evaluation and Commercialization 
Hubs (REACH) Awards (U01) 2.
    Date: August 8, 2023.
    Time: 9:00 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Megan L. Goodall, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-8334 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

     Dated: July 24, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-15992 Filed 7-27-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.